研究显示患者在使用诺和诺德减肥药Wegovy的同时联合服用礼来的实验性药物bimagrumab在减重的同时能够有效保持肌

智通财经
23 Jun
研究显示患者在使用诺和诺德减肥药Wegovy的同时联合服用礼来的实验性药物bimagrumab在减重的同时能够有效保持肌肉质量。据周一在芝加哥举行的美国糖尿病协会年会公布的结果联合用药的患者在48周内体重下降了22.1%其中92.8%为体脂减少。值得注意的是bimagrumab单药组减去的100%体重均来自脂肪且瘦体重增加了2.5%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10